Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma.

Tadaaki Arizumi; Kazuomi Ueshima; Tomohiro Minami; Masashi Kono; Hirokazu Chishina; Masahiro Takita; Satoshi Kitai; Tatsuo Inoue; Norihisa Yada; Satoru Hagiwara; Yasunori Minami; Toshiharu Sakurai; Naoshi Nishida; Masatoshi Kudo

首页> 外文期刊>Liver cancer. >Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma.

【24h】

Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma.

机译：索拉非尼在经导管动脉化疗栓塞（TACE）难治性和中级肝细胞癌患者中的疗效。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Conversion to sorafenib significantly improves the OS in patients refractory to TACE therapy with intermediate-stage HCC. Administration of sorafenib is therefore recommended in such circumstances of TACE treatment failure.

机译：转化为索拉非尼可显着改善中间期HCC对TACE治疗无效的患者的OS。因此，建议在TACE治疗失败的情况下服用索拉非尼。

著录项

来源
《Liver cancer.》 |2015年第4期|共10页
作者
Tadaaki Arizumi; Kazuomi Ueshima; Tomohiro Minami; Masashi Kono; Hirokazu Chishina; Masahiro Takita; Satoshi Kitai; Tatsuo Inoue; Norihisa Yada; Satoru Hagiwara; Yasunori Minami; Toshiharu Sakurai; Naoshi Nishida; Masatoshi Kudo;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma. [J] . Tadaaki Arizumi, Kazuomi Ueshima, Tomohiro Minami, Liver cancer. . 2015,第4期

机译：索拉非尼在经导管动脉化疗栓塞（TACE）难治性和中级肝细胞癌患者中的疗效。
2. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis [J] . Shuanggang Chen, Mengting Shi, Lujun Shen, International journal of hyperthermia: The official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group . 2020,第1期

机译：微波消融与索拉非植物的中间阶段肝细胞癌，具有经截面动脉化疗栓塞耐火材料：倾向得分匹配分析
3. Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization [J] . Ogasawara Sadahisa, Chiba Tetsuhiro, Ooka Yoshihiko, Oncology: International Journal of Cancer Research and Treatment . 2014,第6期

机译：索拉非尼在难治经动脉化疗栓塞的中级肝细胞癌患者中的疗效
4. Lentinan combined radiofrequency ablation and transcatheter arterial chemoembolization for hepatocellular carcinoma [C] . Liang Minghui, Xia Liding 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：慢病毒结合射频消融联合经导管动脉化疗栓塞治疗肝细胞癌
5. Poly(lactide-co-glycolide) Microspheres for Localized, Magnetic Resonance Imaging Monitored, Transcatheter Delivery of Sorafenib to Hepatocellular Carcinoma. [D] . Chen, Jeane. 2015

机译：聚（丙交酯-共-乙交酯）微球体用于局部监测，磁共振成像监测，索拉非尼经导管输送至肝细胞癌。
6. Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma [O] . Tadaaki Arizumi, Kazuomi Ueshima, Tomohiro Minami, 2015

机译：索拉非尼在经导管动脉化疗栓塞（TACE）难治性和中级肝细胞癌患者中的疗效
7. Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma [O] . Tadaaki Arizumi, Kazuomi Ueshima, Tomohiro Minami, 2015

机译：索拉非尼对经截面动脉化疗栓塞（TACE）耐火材料和中期肝细胞癌患者的有效性

Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma.

摘要

著录项

相似文献

相关主题

期刊订阅